tiprankstipranks
Advertisement
Advertisement

PRME Stock Latest News

BMO starts Prime Medicine at Outperform into 2027 readouts
The FlyBMO starts Prime Medicine at Outperform into 2027 readouts
2d ago
PRME
Prime Medicine initiated with an Outperform at BMO Capital
PremiumThe Fly
Prime Medicine initiated with an Outperform at BMO Capital
2d ago
PRME
Prime Medicine Maintained at Buy with Unchanged $6 Price Target on Emerging Program Clarity and 2027 Catalysts
PremiumRatings
Prime Medicine Maintained at Buy with Unchanged $6 Price Target on Emerging Program Clarity and 2027 Catalysts
3d ago
PRME
Prime Medicine Advances First-in-Human Prime Editing Trial in Wilson Disease
PremiumCompany Announcements
Prime Medicine Advances First-in-Human Prime Editing Trial in Wilson Disease
9d ago
PRME
Prime Medicine: Buy Rating Reiterated with Unchanged $5 Price Target on Emerging Clinical Catalysts in Wilson’s Disease
PremiumRatings
Prime Medicine: Buy Rating Reiterated with Unchanged $5 Price Target on Emerging Clinical Catalysts in Wilson’s Disease
14d ago
PRME
Prime Medicine reports Q4 EPS (24c), consensus (26c)
PremiumThe FlyPrime Medicine reports Q4 EPS (24c), consensus (26c)
14d ago
PRME
Prime Medicine Buy Rating Reiterated as Pipeline Advances; $6 Price Target Maintained
Premium
Ratings
Prime Medicine Buy Rating Reiterated as Pipeline Advances; $6 Price Target Maintained
27d ago
PRME
TD Cowen says arbitration decision removes overhang for Prime Medicine’s PM647
Premium
The Fly
TD Cowen says arbitration decision removes overhang for Prime Medicine’s PM647
1M ago
BEAM
PRME
Midday Fly By: U.S. strikes targets in Iran, Trump says ceasefire ‘over’
PremiumThe Fly
Midday Fly By: U.S. strikes targets in Iran, Trump says ceasefire ‘over’
1M ago
EL
KR
Resolution in favor of Prime has limited impact to Beam, says BofA
PremiumThe Fly
Resolution in favor of Prime has limited impact to Beam, says BofA
1M ago
BEAM
PRME
Prime Medicine reports positive resolution to arbitration with Beam Therapeutics
PremiumThe Fly
Prime Medicine reports positive resolution to arbitration with Beam Therapeutics
1M ago
BEAM
PRME
Prime Medicine resolves arbitration, clarifying PM647 development rights
PremiumCompany Announcements
Prime Medicine resolves arbitration, clarifying PM647 development rights
1M ago
8K
PRME
Cathie Wood’s ARK Investment buys 206.2K shares of Prime Medicine today
PremiumThe FlyCathie Wood’s ARK Investment buys 206.2K shares of Prime Medicine today
1M ago
PRME
CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts
Premium
Weekend Updates
CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts
2M ago
WBD
CYTK
Prime Medicine upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Prime Medicine upgraded to Buy from Neutral at H.C. Wainwright
2M ago
PRME
Prime Medicine granted RMAT designation for PM359
PremiumThe Fly
Prime Medicine granted RMAT designation for PM359
2M ago
PRME
Prime Medicine announces New Zealand cleared trial application for PM577a
PremiumThe Fly
Prime Medicine announces New Zealand cleared trial application for PM577a
2M ago
PRME
Prime Medicine Stockholders Reaffirm Board and Auditor Choices
PremiumCompany Announcements
Prime Medicine Stockholders Reaffirm Board and Auditor Choices
2M ago
8K
PRME
Prime Medicine reports Q1 EPS (28c), consensus (25c)
PremiumThe Fly
Prime Medicine reports Q1 EPS (28c), consensus (25c)
4M ago
PRME
Prime Medicine management to meet with Oppenheimer
PremiumThe FlyPrime Medicine management to meet with Oppenheimer
4M ago
PRME
Prime Medicine Appoints Svetlana Makhni as New CFO
Premium
Company Announcements
Prime Medicine Appoints Svetlana Makhni as New CFO
4M ago
8K
PRME
Prime Medicine appoints Makhni as Chief Financial Officer
Premium
The Fly
Prime Medicine appoints Makhni as Chief Financial Officer
4M ago
PRME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >